Axon guidance is a fundamental process in neural development whereby growing axons navigate through the embryonic brain to reach their correct synaptic targets. This highly orchestrated process relies on the precise spatial and temporal distribution of guidance cues that attract or repel growing axons, guiding them to their appropriate destinations within the developing nervous system. While primarily studied in the context of development, increasing evidence demonstrates that axon guidance molecules and pathways play critical roles in adult brain function, neural repair, and neurodegenerative disease pathogenesis. [@biallelic]
The four major families of axon guidance molecules—netrins, semaphorins, ephrins, and Slits—mediate conserved signaling pathways that regulate neural circuit formation and plasticity. These molecules continue to function in the mature nervous system, where they regulate synaptic connectivity, plasticity, and remodeling, and overall brain homeostasis throughout adulthood. Dysregulation of these pathways has been implicated in the pathogenesis of Alzheimer's Disease (AD), Parkinson's Disease (PD), and other neurodegenerative disorders. [@neuronal]
This page provides a comprehensive overview of axon guidance mechanisms and their involvement in neurodegenerative diseases, covering the molecular biology of guidance receptors and ligands, the role of guidance pathways in disease pathogenesis, and emerging therapeutic strategies targeting these pathways. [@molecular]
Axon guidance is a fundamental process in neural development whereby growing axons navigate through the embryonic brain to reach their correct synaptic targets. This highly orchestrated process relies on the precise spatial and temporal distribution of guidance cues that attract or repel growing axons, guiding them to their appropriate destinations within the developing nervous system. While primarily studied in the context of development, increasing evidence demonstrates that axon guidance molecules and pathways play critical roles in adult brain function, neural repair, and neurodegenerative disease pathogenesis. [@biallelic]
The four major families of axon guidance molecules—netrins, semaphorins, ephrins, and Slits—mediate conserved signaling pathways that regulate neural circuit formation and plasticity. These molecules continue to function in the mature nervous system, where they regulate synaptic connectivity, plasticity, and remodeling, and overall brain homeostasis throughout adulthood. Dysregulation of these pathways has been implicated in the pathogenesis of Alzheimer's Disease (AD), Parkinson's Disease (PD), and other neurodegenerative disorders. [@neuronal]
This page provides a comprehensive overview of axon guidance mechanisms and their involvement in neurodegenerative diseases, covering the molecular biology of guidance receptors and ligands, the role of guidance pathways in disease pathogenesis, and emerging therapeutic strategies targeting these pathways. [@molecular]
Axon guidance is mediated by a combination of attractive and repulsive cues that direct axonal growth cones toward their targets. The growth cone, a actin-based motile structure at the tip of extending axons, senses environmental guidance cues through specific receptors and translates these signals into cytoskeletal rearrangements that drive axon extension, steering, or retraction. [@vanbattum2015]
The four major families of guidance molecules are:
Netrins are secreted axon guidance molecules that can act as both attractants and repellents depending on receptor expression. The DCC (Deleted in Colorectal Cancer) receptor mediates attractive responses, while UNC5 receptors convert netrin signals to repulsion. This bifunctional nature allows netrins to provide both positive and negative guidance information to developing axons. [@kolodkin2012]
Key Molecules:
The DCC netrin-1 axis plays a crucial role in synaptic plasticity in the mature brain. DCC is enriched at synapses where it regulates NMDA receptor trafficking and synaptic strength. Loss of DCC function in adult neurons leads to impaired long-term potentiation (LTP) and memory deficits, suggesting that dysregulation of this pathway may contribute to cognitive decline in neurodegenerative diseases. [@yun2018]
Semaphorins are a large family of guidance cues, with Class 3 semaphorins being the most studied in the CNS. Originally identified as axonal repellents, semaphorins have been shown to have diverse functions in neural development, immune regulation, and cancer progression. They primarily function as repulsive cues but can also have attractive effects depending on receptor expression and cellular context. [@mehr2016]
Key Molecules: [@pasterkamp2019]
In Parkinson's Disease, Sema3A may contribute to the vulnerability of dopaminergic neurons. Sema3A expression is elevated in the substantia nigra of PD patients, and this upregulation may inhibit compensatory sprouting of remaining dopaminergic neurons, limiting regenerative capacity. [@choi2014]
Class 3 semaphorins also play important roles in immune regulation. Sema3A and Sema3F regulate microglial activation and migration, and dysregulation of these pathways may contribute to neuroinflammation in neurodegenerative diseases. The crosstalk between semaphorin signaling and microglial receptors like TREM2 suggests that targeting these pathways may have therapeutic potential. [@neuronal]
Ephrin ligands and Eph receptors mediate bidirectional signaling at cell-cell contacts. Unlike other guidance families, both forward (Eph→ephrin) and reverse (ephrin→Eph) signaling can occur, allowing for complex cell-cell communication. The Eph-ephrin system is unique in that both ligands and receptors are membrane-bound, requiring direct cell-cell contact for signaling. [@huberman2014]
Key Molecules:
In Parkinson's Disease, ephrin-Eph signaling may contribute to aberrant sprouting in the basal ganglia. The bidirectional nature of ephrin-Eph signaling allows for complex regulation of neural circuit remodeling, and dysregulation of this system may contribute to maladaptive responses to dopaminergic neuron loss. [@choi2014]
Slit proteins are secreted guidance molecules that repel axons from the midline through Robo (Roundabout) receptors. The Slit-Robo system was originally characterized in Drosophila, where it is essential for midline crossing. In mammals, this pathway regulates axonal guidance in the spinal cord, forebrain, and visual system. [@odonnell2009]
Key Molecules:
Axon guidance molecules continue to function at synapses in the adult brain, where they regulate synaptic structure, function, and plasticity. The continued expression of guidance receptors and ligands at synapses suggests ongoing roles in neural circuit maintenance and modulation. [@pitman2019]
In AD, these mechanisms are disrupted:
Neurodegeneration triggers attempted compensatory sprouting, as damaged neurons attempt to re-establish connections. This regenerative response is typically insufficient or maladaptive, leading to aberrant connectivity patterns that may contribute to network dysfunction. [@low2019]
Key features of aberrant sprouting in neurodegeneration:
White matter lesions in AD and vascular cognitive impairment (VCI) involve disruption of axonal guidance during development and impaired axonal integrity in adulthood. White matter hyperintensities on MRI are a common finding in aging and neurodegeneration, reflecting demyelination, axonal loss, and gliosis. [@cerebrospinal]
Guidance molecules are deposited in white matter and may contribute to the maintenance of axonal integrity. Disruption of these systems may contribute to white matter pathology in neurodegenerative diseases.
In Alzheimer's Disease, axon guidance pathway dysregulation contributes to multiple aspects of pathogenesis:
In Parkinson's Disease, axon guidance pathways affect dopaminergic neuron vulnerability and circuit remodeling:
In ALS, axon guidance molecules may contribute to motor neuron vulnerability and sprouting:
Several therapeutic strategies targeting axon guidance pathways are under investigation:
Guidance molecules show promise as biomarkers for neurodegenerative disease progression:
While no axon guidance-targeted therapies have reached clinical use, several approaches are in preclinical development: